Lianyungang Geri Pharmaceutical Co., LTD., founded in 2004 with a registered capital of 100 million yuan, is a high-tech enterprise specializing in the research and development, production and sales of chemical bulk drugs, pharmaceutical intermediates and preparations. It is one of the important parts of civilian goods business of China Shipbuilding Group 716 Research Institute.
The company has two factories in Songtiao and Dapu, covering a total area of 150,000 m2, and has built office buildings, RESEARCH and development centers, production workshops, warehouses and complete supporting facilities. At present, the company can produce anti-tumor API, freeze-dried powder injection, tablet, hard capsule, small volume injection, non-anti-tumor API and intermediates, etc.
The company has excellent R & D team, capable management team, is one of the first through the national new GMP certification pharmaceutical enterprises. The company has dozens of various patents, and has repeatedly passed the domestic GMP certification, the US FDA on-site inspection and PIC/S international certification. It has won many honorary titles such as "High-tech Enterprise of Jiangsu Province", "Postdoctoral Innovation Practice Base of Jiangsu Province", "Graduate Workstation of Jiangsu Province", "Engineering Technology Research Center of Jiangsu Province" and so on.